Abstract: The main amino acid substitutions within the MHC class II restricted T-cell epitope of HBcAg includes the T12S (15.8%) and T67N (12.3%) mutation and the V27I (10.5%) mutation in the MHC class I restricted T-cell epitope.
Result: Several amino acid substitutions were found within the immune-active region of the HBV core gene including the T12S (9/57, 15.8%) and T67N (7/57, 12.3%) mutation in the MHC class II restricted T-cell epitope of HBV core protein and the V27I (6/57, 10.5%) mutation in the MHC class I restricted T-cell epitope.
Figure: The major mutations in the MHC class I restricted (amino acids 18-27, 88-96, 130-140, 141-151) and MHC class II-restricted (amino
Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.
Result: Overall three mutations in Th epitope (T12S, S35T, T67N) and one in CTL epitope (T147C) of core showed significant association with HCC (p<0.05) (Table 3).
Table: T12S
Discussion: While three mutations in Th epitopes (T12S, S35T, T67N), T147C in CTL epitope and two mutations I116L, P130Q in B cell epitopes showed significant association with disease severity (Table 3).
Naturally occurring core immune-escape and carboxy-terminal mutations runcations in patients with e antigen negative chronic hepatitis B.
Abstract: CONCLUSION: Core immune-escape mutations cT12S, cS21T, cT67P, cE113D, and cP130T/Q are significantly higher in decompensated liver disease patients and could influence the severity of liver disease in HBeAg -ve CHB patients.
Abstract: Three core immune escape mutations were significantly higher in patients with coexisting precore stop codon compared with patients without
CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
Abstract: Substitutions for Ser(21) and Thr12Ser were associated with lower serum levels of HBV DNA (p<0.001).
Result: The Thr12Ser mutation was also found to be correlated with substitutions within CTL epitopes 18-27 (cc=0.43, p=0.0001), and 91-95 (cc=0.40, p=0.0002).